Terre Quinn, MD
Payments from drug & device makers
What this record shows
This record is dominated by other: $5,464 of the $6,032 with a category attached, or 90.6%. Merit Medical Systems Inc accounts for 90.6% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2023 at $5,464 and has fallen 90.6% since, to $513 in 2025.
Across 27 payments — averaging $223.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merit Medical Systems Inc$5K
- Myriad Genetic Laboratories, Inc.$96
- Johnson & Johnson$71
- Sanofi$65
- Pfizer$58
- Jazz Pharmaceuticals Inc.$28
- plus $250 from 12 others
What the payments were for
- Food & beverage$5689%
- Other$5,46491%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merit Medical Systems Inc | 2 | $5,464 |
| Myriad Genetic Laboratories, Inc. | 5 | $96 |
| Johnson & Johnson | 3 | $71 |
| Sanofi | 2 | $65 |
| Pfizer | 2 | $58 |
| Jazz Pharmaceuticals Inc. | 1 | $28 |
| Eisai Inc. | 1 | $28 |
| Davol Inc. | 1 | $27 |
| Tolmar, Inc. | 1 | $25 |
| Daiichi Sankyo Inc. | 1 | $25 |
| Incyte Corporation | 1 | $24 |
| Progenics Pharmaceuticals, Inc. | 1 | $21 |
| Hologic Sales And Service, LLC | 1 | $21 |
| Accord Healthcare, Inc. | 1 | $20 |
| American Regent | 1 | $18 |
| Elucent Medical | 1 | $15 |
| Genentech USA, Inc. | 1 | $14 |
| Iovance Biotherapeutics, Inc. | 1 | $12 |
How this compares
$6,032 in reported general payments places this provider in the 60th percentile of 1,830 surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other surgery in Plano
- Dean CionePlano$322K
- Julianne SantarosaPlano$303K
- Michael HarkinsTomball$2.7M
- Douglas StoddardAustin$1.4M
- Steven FassAustin$989K
- Vineet ChoudhryAustin$851K
- Andy HawthorneRound Rock$843K
- Nancy MarquezAustin$700K
- Sachin KukrejaDallas$640K
- Alejandro EsquivelAustin$631K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.